A New Topical Drug Formulation With Methanol Extract Of CASSIA AURICULATA WITH ALPHA TOCOPHEROL AND POVIDON IODINE VS REGULAR dressing solution for foot ulcer patients
Trial Snapshot
- Phase
- Phase 1
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- The effectiveness of new topical solution in promoting wound healing
Study Overview
Brief Summary
This study provides compelling evidence supporting the use of a herbal-based wound dressing as a viable alternative to conventional synthetic wound care solutions. The formulation, enriched with Cassia auriculata extract, alpha-tocopherol, and povidone-iodine, effectively addresses key challenges in wound healing, including infection control, inflammation modulation, and tissue regeneration.With further optimization to enhance its efficacy—particularly against resistant microbial strains—and rigorous clinical validation, this herbal-based intervention has the potential to revolutionize modern wound care. By integrating scientific advancements with traditional herbal medicine, this formulation offers an effective, natural, and safe alternative for wound healing, paving the way for sustainable and innovative therapeutic solutions in healthcare.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Healthy individuals.
Exclusion Criteria
- •Pregnancy Coronary artery disease.
Outcomes
Primary Outcomes
The effectiveness of new topical solution in promoting wound healing
Time Frame: Day 0,day 3,day 5,day 7
Secondary Outcomes
- Evaluate efficacy of methanol extract of Cassia auriculata with povidone iodine & alpha tocopherol(Day 0,3,5,7)
Investigators
Sri Siva Shyla
Saveetha medical college and hospital
